Amy Klug

Amy Klug is an experienced biopharma business leader currently serving as VP, Chief of Staff for Corporate Strategy & Projects in the CEO Office at Gilead Sciences. They have held various prominent positions including Executive Director roles at Merck and contributed to the oncology business unit in Canada, achieving significant growth. Prior to their current role, Amy conducted impactful research at JPMorgan and King Street Capital Management, focusing on financial analysis and strategic investments. Amy's educational background includes a BA in Political Economy from Georgetown University, an MBA in Finance from NYU Stern School of Business, and studies at The London School of Economics.